Skip to content
PEPTALK
All comparisons

BPC-157 vs TB-500 (Thymosin Beta-4)

Comparing self-reported PepTalk data: BPC-157 does not have enough reports yet to show a cohort figure (n=0), while TB-500 (Thymosin Beta-4) does not have enough reports yet to show a cohort figure (n=0).

BPC-157

Healing & Recovery Peptides

Contributors (n)0
Data points0
Median doseNot enough data
Top reported side effects

Not enough data yet.

TB-500 (Thymosin Beta-4)

Healing & Recovery Peptides

Contributors (n)0
Data points0
Median doseNot enough data
Top reported side effects

Not enough data yet.

Self-reported by users, unverified. Not medical advice and not an endorsement of any substance. 18+ only.